SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

DRMA

Dermata Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.86 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record32820 flagged findings
Reported transactions (Form 4)51since Jan 13, 2025
Corporate events (8-K)30since Aug 3, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Aug 1, 2025) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 328)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 26S-3 ↗Securities offering
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 17, 268-K ↗Current report · Sold unregistered shares
  • Aug 17, 2625-NSE ↗Delisting or deregistration
  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results
  • Aug 5, 268-K ↗Current report · Other events
  • Jun 16, 26Form 4 ↗Insider transaction
  • Jun 1, 26SCHEDULE 13D ↗Stake with intent to influence · Kyri K. Van Hoose · 9.0% · event on May 27, 26
  • May 29, 26424B3 ↗Securities offering
  • May 27, 268-K ↗Current report · A senior executive left or was appointed
  • May 27, 26CORRESP ↗Correspondence with the SEC
  • May 22, 26S-3/A ↗Securities offering · amendment
  • May 13, 2610-Q ↗Quarterly report
  • May 13, 268-K ↗Current report · Results
  • May 13, 26SCHEDULE 13G/A ↗Passive stake · Mitchell P. Kopin · 5.0% · event on Mar 31, 26 · amendment
  • Apr 22, 26SCHEDULE 13G/A ↗Passive stake · BIGGER CAPITAL FUND L P · 1.9% · event on Mar 31, 26 · amendment
  • Apr 17, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 17, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 7, 26PRE 14A ↗Shareholder meeting and votes
  • Mar 26, 2610-K ↗Annual report
  • Mar 26, 268-K ↗Current report · Results
  • Mar 17, 26Form 4 ↗Insider transaction
  • Feb 25, 268-K ↗Current report · A senior executive left or was appointed

328 filings on record, the oldest from Apr 29, 21.

Listing the 25 most recent filings of the 328 on record.

8-Ks, explained

Stress8Structure22Governance12
  • Aug 17, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • May 27, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 25, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 3, 26GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Dec 29, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Nov 18, 25StructureA material agreement was terminated8-K 1.02 ↗
  • Jul 7, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 5, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • May 16, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Mar 28, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 25, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Structure4 material agreements entered2024 – 2025show all 4hide
    • Jan 23, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jan 21, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Sep 17, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jun 7, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

8 older filings not shown · The record reaches back to Sep 1, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 24, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 15, 24StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Nov 16, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Dec 15, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 22, 22StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 8 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Bigger Michael9.9%Dec 31, 25SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Mitchell P. Kopin5.0%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Armistice Capital, LLC5.0%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • BIGGER CAPITAL FUND L P1.9%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 16, 26Sell$13Kathleen D. Scott↗
  • Feb 17, 26Buy$1KMunera Maria E Bedoya-ToroSVP, Regulatory Affairs↗
Stock compensation, tax and giftsshow the 9 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 16, 26Compensationamount n/aHoose Kyri K. VanSVP, CFO↗
  • Aug 16, 26Compensationamount n/aGERALD T PROEHLPRESIDENT, CHAIRMAN, CEO↗
  • Dec 23, 25Compensationamount n/aGERALD T PROEHLPRESIDENT, CHAIRMAN, CEO↗
  • Dec 23, 25Compensationamount n/aGERALD T PROEHLPRESIDENT, CHAIRMAN, CEO↗
  • Dec 23, 25Compensationamount n/aHoose Kyri K. VanSVP, CFO↗
  • Jan 23, 25Compensationamount n/aDAVID F HALE↗
  • Jan 21, 25Compensationamount n/aGERALD T PROEHLPresident, CEO and Chairman↗
  • Jan 21, 25Compensationamount n/aHoose Kyri K. VanSVP, CFO↗
  • Jan 21, 25Compensationamount n/aMARY FISHER↗

The full record holds 11 transactions and goes back to Jan 3, 23.

Its sector and its market

Dermata Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Dermata Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Dermata Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
328 documents on file, from Apr 29, 2021 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.